These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 195003)

  • 21. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients.
    Shah SV; Wallin JD; Eilen SD
    J Clin Endocrinol Metab; 1983 Aug; 57(2):402-9. PubMed ID: 6306042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of human plasma kallikrein on lysosomal enzyme release from polymorphonuclear leukocytes.
    Stancíková M; Rybák M; Simonianová K; Ondrsik M
    Agents Actions; 1991 Mar; 32(3-4):209-12. PubMed ID: 1650520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation.
    Hoffstein S; Goldstein IM; Weissmann G
    J Cell Biol; 1977 Apr; 73(1):242-56. PubMed ID: 856834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of phagocytosis, metabolic stimulation and lysosomal enzyme release in human leukocytes.
    Roos D; Goldstein IM; Kaplan HB; Weissmann G
    Agents Actions; 1976 Feb; 6(1-3):256-9. PubMed ID: 181968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microplate reader assay for measurement of opsonized zymosan-stimulated superoxide anion production by neutrophils.
    Carey LA; Schuhl RA; Gee MH
    Biotechniques; 1995 Nov; 19(5):824-9. PubMed ID: 8588923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine.
    Peck SL; Johnston RB; Horwitz LD
    J Pharmacol Exp Ther; 1985 Nov; 235(2):418-22. PubMed ID: 2997433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion.
    Korchak HM; Eisenstat BA; Hoffstein ST; Dunham PB; Weissmann G
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2721-5. PubMed ID: 6248861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of the glucoprotein component of musk on the functions of rat polymorphonuclear leukocytes activated by fMLP in vitro].
    Wang W; Bai J; Cheng G; Zhu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):222-6. PubMed ID: 10453495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anti-inflammatory drugs on leukocyte superoxide production by soluble and particulate stimuli.
    Spisani S; Marangoni C; Traniello S
    Biochem Int; 1984 Jul; 9(1):1-8. PubMed ID: 6089834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lidocaine on oxygen free radical production by polymorphonuclear neutrophils.
    Siminiak T; Wysocki H
    Agents Actions; 1992; Spec No():C104-5. PubMed ID: 1332451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinchocaine and amethocaine inhibit activation and activity of superoxide production in human neutrophils.
    Irita K; Fujita I; Takeshige K; Minakami S; Yoshitake J
    Br J Anaesth; 1986 Jun; 58(6):639-45. PubMed ID: 3011043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential stimulation of the respiratory burst and lysosomal enzyme secretion in human polymorphonuclear leukocytes by synthetic diacylglycerols.
    Cox CC; Dougherty RW; Ganong BR; Bell RM; Niedel JE; Snyderman R
    J Immunol; 1986 Jun; 136(12):4611-6. PubMed ID: 3011896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of oxidative metabolism in rabbit polymorphonuclear leukocytes by triphenyltin chloride.
    Matsui H; Wada O; Ushijima Y; Mizuta T
    Arch Toxicol; 1983 Nov; 54(3):227-33. PubMed ID: 6318689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tetracaine and bupivacaine on chemiluminescence generated by formyl-methionyl-leucyl-phenylalanine-stimulated human leukocytes and cell-free systems.
    Günaydin B; Demiryürek AT
    Int Immunopharmacol; 2003 May; 3(5):757-64. PubMed ID: 12757744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective initiation of oxidative metabolism in polymorphonuclear leukocytes.
    Harvath L; Andersen BR
    N Engl J Med; 1979 May; 300(20):1130-5. PubMed ID: 219339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse relationship between lysosomal-enzyme release and active-oxygen generation in stimulated human neutrophils.
    Niwa Y; Sakane T; Yokoyama M; Skosey JL; Miyachi Y
    Mol Immunol; 1985 Aug; 22(8):973-80. PubMed ID: 2995796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal enzymes and metabolic activity of polymorphonuclear leukocytes from patients with systemic lupus erythematosus and from experimental animals after levamisole treatment.
    Ferencík M; Rovenský J; Stefanovic J
    Agents Actions; 1982 Oct; 12(4):478-84. PubMed ID: 6295108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface contact inhibits neutrophil superoxide generation induced by soluble stimuli.
    Hoffstein ST; Gennaro DE; Manzi RM
    Lab Invest; 1985 May; 52(5):515-22. PubMed ID: 2985869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.
    Zurier RB; Weissmann G; Hoffstein S; Kammerman S; Tai HH
    J Clin Invest; 1974 Jan; 53(1):297-309. PubMed ID: 4357615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifying effect of vinblastine on superoxide anion production by membrane perturbing agents in polymorphonuclear leukocytes.
    Okamura N; Ishibashi S
    J Biochem; 1982 May; 91(5):1725-30. PubMed ID: 6284732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.